세계의 경화요법 시장 보고서(2025년)

Sclerotherapy Global Market Report 2025

US $ 4,490 ￦ 6,482,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,370,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,257,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

경화요법 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 CAGR 6.4%로 15억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 최소침습적 시술의 채택 증가, 만성 정맥 질환의 유병률 증가, 미용 정맥 치료에 대한 인식 증가, 정맥 전문 클리닉에 대한 접근성 확대, 신흥 시장의 의료비 지출 증가, 외래 환자 치료를 촉진하는 지지적인 규제 이니셔티브와 관련이 있을 수 있습니다. 예측 기간 동안 주요 동향으로는 폼 기반 제제 개발, 초음파 유도 기술 통합, 최소침습적 시술의 채택, 맞춤형 치료 계획 개발, 진단 정확도를 위한 AI 사용, 시술 후 회복 프로토콜 강화, 외래 정맥 클리닉의 확대 등이 있습니다.

하지정맥류와 거미줄 정맥의 유병률 증가는 경화요법 시장의 성장을 촉진할 것으로 예상됩니다. 하지정맥류와 거미줄 정맥은 피부 아래에서 볼 수 있는 확장되거나 꼬이거나 손상된 정맥으로, 주로 다리의 혈액순환 장애로 인해 발생합니다. 이러한 정맥류의 증가는 현대인의 생활습관에 기인하는 바가 큰데, 업무상 습관으로 인해 장시간 앉아있거나 서 있는 경우가 많습니다. 경화요법은 손상된 정맥을 막고 혈류를 개선하며 피부 외관을 개선하는 용액을 표적 주사하여 이 문제를 해결합니다. 예를 들어, 2024년 1월 국립 생물 공학 정보 센터(NCBI)가 발표한 보고서에 따르면 브라질 인구의 47.6%가 정맥류로 고통 받고 있으며, 남성(37.9 %)에 비해 여성의 유병률(50.9 %)이 더 높습니다. 이처럼 정맥류 및 거미줄 정맥의 발생이 증가함에 따라 경화요법 시장의 성장을 크게 촉진할 것으로 예상됩니다.

헬스케어 지출의 증가는 경화요법 시장의 성장을 촉진하고 있습니다. 헬스케어 지출은 국가 및 의료 시스템에서 의료 서비스, 치료 및 건강 관련 자원에 대한 총 지출을 의미합니다. 헬스케어 지출의 증가는 진단과 치료를 개선하는 한편, 개발, 장비, 전문 인력에 대한 막대한 투자를 필요로 하는 첨단 의료 기술의 비용 증가가 주요 원인으로 작용하고 있습니다. 이러한 재정적 지원은 경화요법과 같은 전문치료에 대한 접근성을 높이고, 의료진 및 첨단 장비를 확보할 수 있게 합니다. 예를 들어, 영국 통계청이 2024년 5월에 발표한 바에 따르면 2024년 영국의 의료비 지출은 약 4,213억 2,000만 달러(3,170억 파운드)로 2023년 대비 6.5% 증가할 것으로 예상했습니다. 따라서 의료비 지출 증가 추세는 지속될 것으로 예상되며, 이는 경화요법 시장의 성장에 박차를 가할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 경화요법 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 경화요법 시장 : 성장률 분석
• 세계의 경화요법 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 경화요법 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 경화요법 전체 시장(TAM)

제6장 시장 세분화

• 세계의 경화요법 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 액체 경화요법
• 폼 경화요법
• 초음파 유도 경화요법
• 세계의 경화요법 시장 : 약제별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 세제
• 화학 자극물
• 삼투압제
• 세계의 경화요법 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 정맥류
• 거미정맥류
• 치질
• 세계의 경화요법 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 외래 수술 센터
• 전문 클리닉
• 기타
• 세계의 경화요법 시장, 액체 경화요법 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 폴리도카놀 기반
• 테트라데실황산나트륨(STS) 기반
• 고장성 식염수 기반
• 세계의 경화요법 시장, 폼 경화요법 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 폴리도카놀 폼
• STS 폼
• 공기 기반 폼
• 세계의 경화요법 시장, 초음파 유도 경화요법 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 폼 유도
• 액체 유도
• 병용요법

제7장 지역별·국가별 분석

• 세계의 경화요법 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 경화요법 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 경화요법 시장 : 경쟁 구도
• 경화요법 시장 : 기업 개요
  • Bayer AG
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Novartis AG

제31장 기타 주요 기업과 혁신적 기업

• Medtronic plc
• Boston Scientific Corporation
• Olympus Corporation
• Smith & Nephew plc
• Teleflex Incorporated
• Cook Medical
• Merz Pharma GmbH & Co. KGaA
• AngioDynamics Inc.
• Bioniche Pharma Group Ltd
• Omega Pharmaceuticals Pvt. Ltd.
• Endo-Flex
• Kreussler
• Vascular Solutions, Inc.
• LGM Pharma
• BTG International Ltd.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

• 경화요법 시장, 2029년 : 새로운 기회를 제공하는 국가
• 경화요법 시장, 2029년 : 새로운 기회를 제공하는 부문
• 경화요법 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Sclerotherapy is a minimally invasive procedure used to treat varicose and spider veins by injecting a concentrated solution (sclerosant) directly into the affected veins. The sclerosant irritates the vein lining, causing it to collapse, scar, and eventually be reabsorbed by the body. Over time, the treated veins fade, and blood flow is redirected through healthier vessels.

The main types of sclerotherapy are liquid sclerotherapy, foam sclerotherapy, and ultrasound-guided sclerotherapy. Liquid sclerotherapy involves injecting a solution into the affected veins and is used to treat varicose and spider veins. The procedure employs various agents, including detergents, chemical irritants, and osmotic agents. These are used for applications such as varicose veins, spider veins, and hemorrhoids, serving various end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

The sclerotherapy market research report is one of a series of new reports from The Business Research Company that provides sclerotherapy market statistics, including the sclerotherapy industry global market size, regional shares, competitors with the sclerotherapy market share, detailed sclerotherapy market segments, market trends, and opportunities, and any further data you may need to thrive in the sclerotherapy industry. This sclerotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sclerotherapy market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be attributed to the rising prevalence of varicose veins, an increasing aging population, growing demand for minimally invasive procedures, improved healthcare infrastructure, greater awareness of aesthetic treatments, and expanding insurance coverage for vein-related conditions.

The sclerotherapy market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth during the forecast period can be linked to the increasing adoption of minimally invasive procedures, the rising prevalence of chronic venous disorders, growing awareness of cosmetic vein treatments, expanding access to specialized vein clinics, increased healthcare expenditure in emerging markets, and supportive regulatory initiatives promoting outpatient treatments. Key trends in the forecast period include advancements in foam-based formulations, integration of ultrasound-guided techniques, adoption of minimally invasive procedures, development of personalized treatment plans, use of AI for diagnostic precision, enhanced post-procedure recovery protocols, and the expansion of outpatient vein clinics.

The growing prevalence of varicose veins and spider veins is anticipated to drive the expansion of the sclerotherapy market. Varicose and spider veins are enlarged, twisted, or damaged veins that are visible under the skin, primarily caused by poor blood circulation, particularly in the legs. This rise in prevalence is largely attributed to modern lifestyles, where people spend long hours sitting or standing, often due to work-related habits. Sclerotherapy addresses this issue by using targeted injections of a solution that seals off damaged veins, improving blood flow and the appearance of the skin. For example, a January 2024 report from the National Center for Biotechnology Information (NCBI) noted that in Brazil, 47.6% of the population suffered from varicose veins, with women having a higher prevalence (50.9%) compared to men (37.9%). As such, the increasing occurrence of varicose and spider veins is expected to significantly boost the growth of the sclerotherapy market.

The rising healthcare expenditure is driving the growth of the sclerotherapy market. Healthcare expenditure refers to the total spending on medical services, treatments, and health-related resources within a country or healthcare system. The rise in healthcare spending is largely attributed to the increasing costs of advanced medical technologies, which, while improving diagnosis and treatment, require substantial investment in development, equipment, and specialized personnel. This financial support enhances access to specialized treatments such as sclerotherapy, ensuring availability of medical staff and cutting-edge equipment. For instance, the Office for National Statistics in the UK reported in May 2024 that healthcare expenditure in the UK reached approximately $421.32 billion (£317 billion) in 2024, marking a 6.5% increase compared to 2023. Therefore, the upward trend in healthcare expenditure is expected to continue fueling the growth of the sclerotherapy market.

Major companies in the sclerotherapy market are forming strategic partnerships to enhance their research capabilities and broaden their product offerings. These collaborations aim to strengthen their presence through shared expertise and global distribution networks. Advanced, minimally invasive treatments for varicose veins, such as sclerotherapy, laser therapy, and radiofrequency ablation, offer effective solutions to close or remove damaged veins with minimal pain, quick recovery, and fewer complications. For example, in February 2025, Aakash Healthcare, a specialty hospital in India, partnered with Medtronic plc, a US-based healthcare company, to launch a specialized vein clinic. This clinic offers advanced, minimally invasive treatments for varicose veins and other vein-related conditions, providing patients with faster recovery and long-term health benefits. Additionally, the clinic offers personalized treatment plans and post-treatment care, ensuring a comprehensive approach to vein health and overall well-being.

Major players in the sclerotherapy market are Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew plc, Teleflex Incorporated, Cook Medical, Merz Pharma GmbH & Co. KGaA, AngioDynamics Inc., Bioniche Pharma Group Ltd, Omega Pharmaceuticals Pvt. Ltd., Endo-Flex, Kreussler, Vascular Solutions, Inc., LGM Pharma, BTG International Ltd.

North America was the largest region in the sclerotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sclerotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sclerotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sclerotherapy market consists of revenues earned by entities by providing services such as spider vein removal, cosmetic vein treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The sclerotherapy market also includes sales of polidocanol asclera, hypertonic saline, sodium tetradecyl sulfate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sclerotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sclerotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sclerotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sclerotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Liquid Sclerotherapy; Foam Sclerotherapy; Ultrasound-Guided Sclerotherapy
• 2) By Agents: Detergents; Chemical Irritants; Osmotic Agents
• 3) By Application: Varicose Veins; Spider Veins; Hemorrhoids
• 4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Liquid Sclerotherapy: Polidocanol-based, Sodium Tetradecyl Sulfate (STS)-based, Hypertonic Saline-based
• 2) By Foam Sclerotherapy: Polidocanol Foam, STS Foam, Air-based Foam
• 3) By Ultrasound-Guided Sclerotherapy: Foam-guided, Liquid-guided, Combination Therapies
• Companies Mentioned: Bayer AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sclerotherapy Market Characteristics

3. Sclerotherapy Market Trends And Strategies

4. Sclerotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sclerotherapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sclerotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sclerotherapy Market Growth Rate Analysis
• 5.4. Global Sclerotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sclerotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sclerotherapy Total Addressable Market (TAM)

6. Sclerotherapy Market Segmentation

• 6.1. Global Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Sclerotherapy
• Foam Sclerotherapy
• Ultrasound-Guided Sclerotherapy
• 6.2. Global Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Detergents
• Chemical Irritants
• Osmotic Agents
• 6.3. Global Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Varicose Veins
• Spider Veins
• Hemorrhoids
• 6.4. Global Sclerotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Other End-Users
• 6.5. Global Sclerotherapy Market, Sub-Segmentation Of Liquid Sclerotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polidocanol-Based
• Sodium Tetradecyl Sulfate (STS)-Based
• Hypertonic Saline-Based
• 6.6. Global Sclerotherapy Market, Sub-Segmentation Of Foam Sclerotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polidocanol Foam
• STS Foam
• Air-Based Foam
• 6.7. Global Sclerotherapy Market, Sub-Segmentation Of Ultrasound-Guided Sclerotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Foam-Guided
• Liquid-Guided
• Combination Therapies

7. Sclerotherapy Market Regional And Country Analysis

• 7.1. Global Sclerotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sclerotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sclerotherapy Market

• 8.1. Asia-Pacific Sclerotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sclerotherapy Market

• 9.1. China Sclerotherapy Market Overview
• 9.2. China Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sclerotherapy Market

• 10.1. India Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sclerotherapy Market

• 11.1. Japan Sclerotherapy Market Overview
• 11.2. Japan Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sclerotherapy Market

• 12.1. Australia Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sclerotherapy Market

• 13.1. Indonesia Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sclerotherapy Market

• 14.1. South Korea Sclerotherapy Market Overview
• 14.2. South Korea Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sclerotherapy Market

• 15.1. Western Europe Sclerotherapy Market Overview
• 15.2. Western Europe Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sclerotherapy Market

• 16.1. UK Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sclerotherapy Market

• 17.1. Germany Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sclerotherapy Market

• 18.1. France Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sclerotherapy Market

• 19.1. Italy Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sclerotherapy Market

• 20.1. Spain Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sclerotherapy Market

• 21.1. Eastern Europe Sclerotherapy Market Overview
• 21.2. Eastern Europe Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sclerotherapy Market

• 22.1. Russia Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sclerotherapy Market

• 23.1. North America Sclerotherapy Market Overview
• 23.2. North America Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sclerotherapy Market

• 24.1. USA Sclerotherapy Market Overview
• 24.2. USA Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sclerotherapy Market

• 25.1. Canada Sclerotherapy Market Overview
• 25.2. Canada Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sclerotherapy Market

• 26.1. South America Sclerotherapy Market Overview
• 26.2. South America Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sclerotherapy Market

• 27.1. Brazil Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sclerotherapy Market

• 28.1. Middle East Sclerotherapy Market Overview
• 28.2. Middle East Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sclerotherapy Market

• 29.1. Africa Sclerotherapy Market Overview
• 29.2. Africa Sclerotherapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sclerotherapy Market, Segmentation By Agents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sclerotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sclerotherapy Market Competitive Landscape And Company Profiles

• 30.1. Sclerotherapy Market Competitive Landscape
• 30.2. Sclerotherapy Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Sclerotherapy Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Boston Scientific Corporation
• 31.3. Olympus Corporation
• 31.4. Smith & Nephew plc
• 31.5. Teleflex Incorporated
• 31.6. Cook Medical
• 31.7. Merz Pharma GmbH & Co. KGaA
• 31.8. AngioDynamics Inc.
• 31.9. Bioniche Pharma Group Ltd
• 31.10. Omega Pharmaceuticals Pvt. Ltd.
• 31.11. Endo-Flex
• 31.12. Kreussler
• 31.13. Vascular Solutions, Inc.
• 31.14. LGM Pharma
• 31.15. BTG International Ltd.

32. Global Sclerotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sclerotherapy Market

34. Recent Developments In The Sclerotherapy Market

35. Sclerotherapy Market High Potential Countries, Segments and Strategies

• 35.1 Sclerotherapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sclerotherapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sclerotherapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료